Neurology

Ataxia and tolerance after thalamic deep brain stimulation for essential tremor.


Ataxia and tolerance after thalamic deep brain stimulation for essential tremor.

Parkinsonism Relat Disord. 2020 Sep 10;80:47-53

Authors: Chiu SY, Nozile-Firth K, Klassen BT, Adams A, Lee K, Van Gompel JJ, Hassan A

Abstract
BACKGROUND: Deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) thalamus is highly effective to treat medication-refractory essential tremor (ET). Complications of stimulation-induced ataxia and tolerance have been reported in limited series, ranging from 5 to 40%.
OBJECTIVE: We analyzed a large single-center cohort of ET patients treated with thalamic DBS to assess rates of ataxia and tolerance.
METHODS: Retrospective study of all ET patients that underwent VIM DBS at Mayo Clinic from 2010 to 2014. Demographic, clinical and DBS data were extracted. Risk factors, complications and time to onset of tolerance and ataxia were examined.
RESULTS: One hundred and thirteen ET patients (51% male) of mean age 68 ± 10 years and mean ET duration 27 ± 18 years underwent DBS during the study period. Of these, 98 (87%) had follow-up of ≥6 months (mean 4.0 ± 1.5 years) and were included for analysis. Complications of isolated ataxia (26%), isolated tolerance (4%), both tolerance and ataxia (9%), or neither (61%) were identified. Development of ataxia was about 3 times more common than tolerance (35% vs. 13%). The mean time to ataxia was 5.5 ± 0.3 years postoperatively. Risk factors for ataxia were baseline ataxic features, older age, and shorter ET disease duration. Small sample size limited calculation of risk factors and onset time for tolerance.
CONCLUSIONS: Stimulation-related ataxia occurred in one-third of ET patients, while tolerance was less common. Presence of baseline ataxia, age, and disease duration may aid counseling of stimulation-related ataxia risk. Larger studies are warranted to confirm these findings and further assess risk factors for tolerance.

PMID: 32950784 [PubMed – as supplied by publisher]

Source link

Related posts

NPR: How the human brain helps you sing or say what you mean

Newsemia

AANEM 2018: Key Programming on Neuromuscular and Electrodiagnostic Medicine

Newsemia

Subclinical thiamine deficiency identified by pretreatment evaluation in an esophageal cancer patient

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World